Kihealth Labs
Kihealth Labs leadership walking through a modern molecular diagnostics laboratory

Leadership Driven by Science. United by Purpose.

Kihealth Labs brings together leaders in molecular diagnostics, laboratory medicine, clinical research, and biotechnology to advance a new generation of precision metabolic diagnostics — designed to detect disease earlier and enable smarter intervention.

Meet the team Our principles
6
Executive Leaders
3
Board Members
5
Scientific & Clinical Advisors
National
Reach & Partnerships

Executive Team

The people driving precision diagnostics forward.

Jenna Anderson, Chief Executive Officer & Co-Founder

Chief Executive Officer & Co-Founder

Jenna Anderson

Jenna Anderson is the Co-Founder and Chief Executive Officer of Kihealth, where she leads the company's strategy, commercialization, fundraising, and growth initiatives. With more than two decades of experience spanning healthcare, biotechnology, digital health, and consumer wellness, Jenna has built and scaled innovative organizations at the intersection of science and technology. Prior to Kihealth, she held executive leadership positions with AccessElite, Concierge Key Health, ALPHAEON Corporation, and Allergan.

Strategic VisionGrowth LeadershipInvestor Relations

Jenna@kihealth.com

Robert E. Mons III, Chief Operations Officer & Co-Founder

Chief Operations Officer & Co-Founder

Robert E. Mons III

Robert E. Mons III is the Co-Founder and Chief Operations Officer of Kihealth, where he oversees operations, business development, strategic partnerships, government affairs, and corporate growth. Robert spent six years in the United States Congress and held senior leadership roles in Florida state government, bringing deep experience in healthcare policy, public affairs, and regulatory strategy.

OperationsPublic AffairsRegulatory Strategy

Robert@kihealth.com

Dr. Matthew R. Benson, MD, Chief Medical Officer

Chief Medical Officer

Dr. Matthew R. Benson, MD

Dr. Matthew Benson is a board-certified pediatric endocrinologist and nationally recognized diabetes specialist. He serves as Medical Director of the Northeast Florida Pediatric Diabetes Center at Nemours Children's Health and provides clinical leadership across research, regulatory strategy, physician engagement, and product development for Kihealth.

Board CertifiedClinical StrategyTranslational Research

Matthew@kihealth.com

Dr. Clifford Morris, PhD, Chief Scientific Officer

Chief Scientific Officer

Dr. Clifford Morris, PhD

Dr. Clifford Morris is a molecular biologist and diagnostics innovator with extensive experience in biomarker discovery, translational research, assay development, and precision medicine. He leads scientific strategy, research collaborations, and platform expansion across Kihealth's molecular diagnostics portfolio.

PhDBiomarker DiscoveryAssay Development

Clifford@kihealth.com

Dr. Ioan Cucoranu, MD, FCAP, Laboratory Director

Laboratory Director

Dr. Ioan Cucoranu, MD, FCAP

Dr. Ioan Cucoranu is an accomplished laboratory physician and molecular diagnostician. As Laboratory Director, he oversees clinical laboratory operations, quality systems, assay implementation, and regulatory compliance — ensuring the highest standards of scientific rigor and analytical performance.

MD, FCAPCLIA CertifiedMolecular Pathology

Ioan@kihealth.com

Marshall Jaroch, Vice President, Research & Development

Vice President, Research & Development

Marshall Jaroch

Marshall Jaroch leads research and development at Kihealth and plays a critical role in assay development, analytical validation, platform optimization, and translational research — bridging scientific innovation with real-world clinical application.

R&D LeadershipValidationMethodology

Marshall@kihealth.com

Inside the Kihealth Labs molecular diagnostics laboratory.

Inside the Kihealth Labs molecular diagnostics laboratory.

Our Journey

From Yale science to a global diagnostics platform.

  1. 2010s

    Yale Technology

    Foundational immunology and biomarker science emerges from Yale-affiliated research programs.

  2. 2021

    Kihealth Founded

    Founding team unites operators, clinicians, and scientists around earlier disease detection.

  3. 2022

    Platform Development

    InterceptIQ™ molecular diagnostics platform takes shape across multi-omic biomarker classes.

  4. 2023

    Clinical Validation

    Analytical and clinical validation studies establish performance for first indications.

  5. 2024

    Academic Partnerships

    Collaborations with leading academic medical centers expand evidence and reach.

  6. 2025

    Commercial Launch

    BetaIntercept™ T1D and T2D begin commercial roll-out through physician channels.

  7. 2026+

    Global Expansion

    Scaling internationally across metabolic, autoimmune, and adjacent disease areas.

Clinical and scientific leadership reviewing molecular data.

Clinical and scientific leadership reviewing molecular data.

Our Guiding Principles

The values that shape every program we build.

Science First

Every decision is grounded in rigorous, reproducible molecular science.

Integrity

We hold ourselves to the highest standards of ethics, transparency, and quality.

Collaboration

We work shoulder-to-shoulder with clinicians, researchers, and institutions.

Innovation

We translate breakthrough biology into practical clinical tools.

Patient-Centered Care

Patients sit at the center of every program we build.

Evidence-Based Medicine

Peer-reviewed evidence anchors our claims, our assays, and our roadmap.

Scientific & Clinical Advisors

A standing council of field-defining scientists.

Our advisors guide program data review, biomarker discovery, and clinical study design — bringing world-class expertise across diabetes, endocrinology, cell transplantation, and biotech strategy.

Eitan Akirav, PhD

Scientific Advisor

Director of Business Development, Harvard University

Dual focus on scientific innovation and biotech business strategy.

Portrait of Dr. Camillo Ricordi

Dr. Camillo Ricordi

Scientific Advisor

Director Emeritus, Diabetes Research Institute, University of Miami

Internationally renowned physician-scientist and pioneer in diabetes research, regenerative medicine, and cellular transplantation.

Portrait of Dr. Kevan Herold

Dr. Kevan Herold

Scientific Advisor

Professor of Immunobiology & Medicine, Yale School of Medicine

World-leading expert in Type 1 diabetes prevention and immunotherapy; central to the development of teplizumab.

Portrait of Dr. Larry Fox

Dr. Larry Fox

Clinical Advisor

Chief of Pediatric Endocrinology, Nemours Children's Health

34+ years in pediatric endocrinology, clinical research, and integration of novel diagnostics into care.

Portrait of Dr. Shadi Abdelnour

Dr. Shadi Abdelnour

Clinical Advisor

Endocrinologist, Cedars-Sinai Medical Center

Board-certified endocrinologist combining evidence-based care with advances in precision metabolic medicine.

Board of Directors

Independent oversight. Operator pedigree.

Kihealth's board pairs deep capital-markets discipline with operators who have scaled category-defining companies — guiding strategy, governance, and long-horizon value creation.

Portrait of Scott A. Blum

Chairman of the Board

Scott A. Blum

Founder, ThinkTank Holdings · Founder, Buy.com

Visionary entrepreneur and founder of ThinkTank Holdings LLC, a private investment firm focused on technology, commerce, and media. Founder of Buy.com — one of the earliest and most successful e-commerce platforms — with deep expertise scaling category-defining ventures.

ScalingCapital StrategyDisruption
Portrait of Parker Kelley, CPA

Board Member

Parker Kelley, CPA

Kramer-Wilson Company · fmr. CFO, KW Specialty Insurance

Seasoned financial strategist and California CPA with a career spanning corporate finance, public accounting, and investment management. Founding CFO of KW Specialty Insurance, where he built the company to a $101M statutory surplus and an A.M. Best A- (Excellent) rating.

Fiscal StrategyOperationsInvestment Structuring
Portrait of Cameron Gray, PhD, JD

Board Member

Cameron Gray, PhD, JD

Founder & CEO, Alcedo Capital · fmr. MD, MDB Capital Group

Distinguished biotechnology and investment leader. PhD in Biophysics (University of Virginia), JD (George Washington University Law School). Previously Managing Director at MDB Capital Group funding disruptive technology companies.

BiotechCapital MarketsIP Strategy
Kihealth Labs scientific team collaborating in the laboratory

Our Culture

Building More Than a Company

Kihealth Labs is built on scientific curiosity, translational research, and a collaborative culture that connects molecular scientists, clinicians, and academic partners. We pursue clinical excellence with mission-driven innovation — focused on detecting disease earlier and improving outcomes at scale.

  • Scientific curiosity
  • Translational research
  • Collaborative culture
  • Academic partnerships
  • Clinical excellence
  • Mission-driven innovation

Join Us in Building the Future of Metabolic Diagnostics

Whether you are a scientist, physician, partner, or investor — we'd love to hear from you.

Careers Research PartnershipsProvider PartnershipsContact Leadership